MBX Biosciences Announces Successful End-of-Phase 2 FDA Meeting and Provides Phase 3 Development Plan for Once-Weekly Canvuparatide for Hypoparathyroidism
Following End-of-Phase 2 meeting, MBX remains on track to initiate [...]
Medicus Pharma reports positive Phase 2 SKNJCT-003 Topline Data observing 73% Clinical Clearance and 40% Histological Clearance at day 57
The company is expected to finalize the Clinical Study Report [...]
Gut Bacteria and Diet Can Reprogram Fat to Burn More Energy According to A Recent Study
Findings published in Nature uncover a microbiome-driven pathway that turns [...]
Blue Earth Diagnostics Reports Favorable Head‑to‑Head Study Results Comparing POSLUMA® (Flotufolastat F 18) and Piflufolastat F 18 for Assessing Urinary Bladder Radioactivity in Men with Biochemical Recurrent Prostate Cancer
“This rigorous head-to-head study provides high-quality evidence that POSLUMA has [...]
Study highlights GLP-1 companion effects, underscoring capability of Brightseed’s AI platform to identify and launch clinically-validated, natural health innovations
The study was published in the peer-reviewed journal Bioactive Compounds [...]
Jupiter Endovascular Reports pivotal trial completed for flexible-to-stable catheter technology for pulmonary embolectomy
Trial Evaluates Safety, Right Heart Functional Improvement, and Clinical Outcomes [...]
Endospan Announces Positive 1 YR Data from TRIOMPHE FDA Pivotal Study For the NEXUS® Aortic Arch Stent-Graft System
The one-year results for the 94 high surgical risk patients [...]
First Patient Treated in Myra Vision’s U.S. ADAPT Clinical Study for Glaucoma
The Calibreye System is for investigational use only and is [...]
Study showed MiniMed™ 780G system achieved ADA-recommended time-in-range goals even on days users forgot to bolus
“These findings underscore the advanced capabilities of the MiniMed 780G [...]
Pivotal trial completed for system that makes breast cancer easier to remove
he BCL System is designed to improve the accuracy of [...]